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Release of extracellular DNA (eDNA) was observed during in vitro growth of a clinical strain of Acinetobacter baumannii.
Membrane vesicles (MV) of varying diameter (20–200nm) containing DNA were found to be released by transmission electron
microscopy (TEM) and atomic force microscopy (AFM). An assessment of the characteristics of the eDNA with respect to size,
digestion pattern by DNase I/restriction enzymes, and PCR-sequencing, indicates a high similarity with genomic DNA. Role
of eDNA in static bioﬁlm formed on polystyrene surface was evaluated by bioﬁlm augmentation assay using eDNA available
in diﬀerent preparations, for example, whole cell lysate, cell-free supernatant, MV suspension, and puriﬁed eDNA. Bioﬁlm
augmentation was seen up to 224.64%, whereas bioﬁlm inhibition was 59.41% after DNase I treatment: conﬁrming that eDNA
facilitates bioﬁlm formation in A. baumannii. This is the ﬁrst paper elucidating the characteristics and role of eDNA in A.
baumannii bioﬁlm, which may provide new insights into its pathogenesis.
1.Introduction
Pathogenesis and multidrug resistance of Acinetobacter bau-
mannii has been a serious concern in the management of
infections caused by the organism worldwide. It contributes
to 2–10% of all Gram negative infections and 9% of total
nosocomial infections [1, 2]. Associated mortality up to 30%
[3]i ss e e nw i t hA. baumannii i n f e c t i o n ss u c ha sv e n t i l a t o r -
associated pneumonia, bacteraemia, urinary tract infections,
burn wound infections, endocarditis, secondary meningitis,
and septicemia, especially in intensive care units [2, 4, 5].
A. baumannii has the capacity of acquiring putative genetic
factors as plasmids and pathogenicity islands and exhibits
high-level of multidrug, and metal resistance [6, 7]. Global
rise of multidrug-resistant A. baumannii[8], therefore, poses
a major challenge to current treatment options. Bioﬁlm
formation is considered as a factor contributing to the
pathogenicity of A. baumannii, and it imparts high levels of
drug resistance that lead to treatment failure. The capacity of
this bacterium to adhere to epithelial cells is due to a positive
correlation of bioﬁlm formation with adherence [9]a n d
probably explains the clinical success of A. baumannii [10].
In A. baumannii ATCC 19606, a two-component regulatory
system bfmRS is found to play an important role in bioﬁlm
formation and cellular morphology [11].
Bacterial cell aggregation and bioﬁlm formation on
surfaces is a complex process that involves a series of
highly regulated molecular events and the participation of
multiple determinants. These structures are found encased
in an extracellular matrix composed of carbohydrates
and polysaccharides, proteins, other macromolecules, and
nucleic acids, for example, DNA and RNA [12]. It has been
seen that a signiﬁcant fraction of the bioﬁlm matrix can
be only DNA. For instance, extracellular DNA can be up
to 50% more abundant than cellular DNA in unsaturated
bioﬁlms of Pseudomonas aeruginosa [13]. eDNA was ﬁrst
demonstrated to be a matrix component of P. aeruginosa
bioﬁlms[14].ItwasalsoreportedthateDNAoriginatesfrom
the intracellular DNA under conditions in which lysis is not
observed [15]. In case of Staphylococcus epidermidis [16]a n d2 The Scientiﬁc World Journal
Enterococcus faecalis [17], eDNA results from the autolysin-
mediated killing of a small subpopulation of cells, to provide
DN Aasacomponentofbioﬁlmmatrix.Arecentstudysho ws
that eDNA can be released via autolysis and can be a major
contributor to vancomycin-enhanced bioﬁlm formation in
Staphylococcus aureus [18].
Bioﬁlm formation by A. baumannii [19, 20] has facil-
itated its survival on dry surface and enhanced antibiotic
resistance,resultinginA.baumanniiasapersistentinfectious
agent in intensive care units (ICUs). Our recent investigation
[21] shows that bioﬁlm formation by A. baumannii strains
on clinical devices, such as urinary catheters, could explain
their ability to persist in clinical environments and their
role in device-related infections. Nevertheless, the available
knowledge on the speciﬁc molecular determinants in the
development of bioﬁlms in A. baumannii is scarce. We
hypothesize that eDNA could be one such critical determi-
nant.AlthoughstudiesoneDNAanditsroleinnaturaltrans-
formation in Acinetobacter have been reported earlier [22–
25], to date eDNA remains an uncharacterized determinant
in the pathogenic bacterium A. baumannii. Since bioﬁlm
formation is a major virulence factor in A. baumannii,
characterization of eDNA from A. baumannii with regard
to bioﬁlm development is worthwhile investigating. In this
study, we have characterized eDNA from a multidrug-
resistant clinical strain of A. baumannii a n dd e m o n s tra t e di t s
role in in vitro b i o ﬁ l mf o r m a t i o no na b i o t i cs u r f a c e s .
2.MaterialandMethods
2.1. Bacterial Culture and Growth Conditions. A clinical
strain of Acinetobacter baumannii AIIMS 7, previously
isolated [26], was used in this study. The species level iden-
tiﬁcation was done by chromosomal DNA transformation
assay, API 32 GN System [27, 28] and conﬁrmed by
16SrRNA gene sequencing (GenBank accession EU779829).
Phenotypic identiﬁcation was performed using biochemical
assays [29]. The bacterium was grown and maintained on
cysteine-lactose electrolyte deﬁcient (C.L.E.D.) agar and in
Luria broth (HiMedia, India) with appropriate antibiotics
at 37◦C. The antibiotic resistance proﬁle was determined
according to Clinical and Laboratory Standards Institute
(CLSI) protocols. Growth curve of A. baumannii AIIMS 7
was analyzed up to 96 hours, by taking absorbance at 600nm
in a UV-Vis spectrophotometer (Shimadzu, Japan).
2.2. Puriﬁcation of eDNA in Temporal Scale of Growth. eDNA
was puriﬁed from cell-free supernatant ﬁltered through
0.22μm syringe ﬁlters (PALL, USA) sampled at various time
points of growth up to 96 hours using methods described
elsewhere [30] with modiﬁcations. Brieﬂy, 750μLo fc e l l -
free supernatant was added to an equal volume of buﬀer-
A (50mM Tris, 10mM EDTA with 1% cetyl trimethyl
ammonium bromide (CTAB), pH 8.0 and incubated at 65◦C
for 30min, followed by centrifugation at 6500g for 10min.
To the pellet, 500μLo fb u ﬀer-B (10mM Tris, 0.1mM EDTA
and1MNaCl,pH8.0.)wasaddedfollowedby0.3volumesof
ice-coldisopropanol.Afterincubationforthreehoursat4◦C,
the precipitated DNA was centrifuged at 12000g for 15min,
to obtain the pellet which was ﬁnally resuspended in 40μL
of DNase RNase free Tris-EDTA buﬀer (10mM Tris-Cl pH
8.0, 1mM EDTA, Sigma Aldrich, USA). The pellet was solu-
bilised at 4◦C overnight. To eliminate proteins, samples were
treated with Proteinase K (10mg/mL, Sigma Aldrich, USA)
and incubated at 37◦C for one hour and reprecipitated with
ice-cold isopropanol. Genomic DNA was also puriﬁed using
a commercial kit (Sigma Aldrich, USA). Concentrations of
D N Aw e r ed e t e r m i n e di naB i o p h o t o m e t e rP l u s( E p p e n d o r f ,
Germany).
2.3. Puriﬁcation of Membrane Vesicles. To check whether
total eDNA found in cell-free supernatant originates from
membrane vesicles, their presence was tested during active
growth phase of A. baumannii AIIMS 7. Membrane vesicle
puriﬁcation was done from cell-free supernatant as per
methods described elsewhere [31]. Brieﬂy, Luria broth
(150mL) was inoculated with 106CFU/mL of A. bau-
mannii AIIMS 7 and incubated at 37◦C for 15 hours at
150rpm. Cells were pelleted and supernatant was sequen-
tially ﬁltered through a 0.45μma n da0 . 2 2 μmp o r eﬁ l t e r
(PALL, USA). Filtered cell-free supernatant was subjected
to ultracentrifugation (141,000g, three hours, 4◦C) in an
Ultracentrifuge (Beckmann, USA). Pellet was resuspended
in 50mM of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES) buﬀer supplemented with 0.5mM dithiothre-
itol (DTT) (HiMedia, India). The puriﬁed membrane vesicle
suspension was treated with DNase I (10mg/mL, Sigma
Aldrich) to remove any unencapsulated eDNA, was again
ﬁltered through a 0.22μm syringe ﬁlter to remove any cells
leftover, and was stored at −20◦C until use.
2.4. Visualization of Membrane Vesicles by Electron Micros-
copy. The puriﬁed membrane vesicle suspension was local-
ized by transmission electron microscopy using methods
described earlier [32]. Brieﬂy, 20μL puriﬁed membrane vesi-
cle suspension was placed on carbon and Formvar precoated
copper grids, washed by ﬂoating in 50μLo fm o l e c u l a rg r a d e
water and stained with 2% uranyl acetate and dried. Stained
grids were examined in a Transmission Electron Microscope
(JEOL, Japan) operating under standard conditions. For
atomic force microscopy, 10μL of puriﬁed membrane vesicle
suspension was placed on freshly cleaved mica for 1min and
air dried. To minimize damage to membrane vesicles, a small
deﬂection signal of −0.5V (operating in contact mode) was
appliedandvisualizedwithaslowscanrateof0.25to0.50Hz
in an Atomic Force Microscope (JEOL, Japan).
2.5. Digestion of eDNA by DNase I and Restriction Enzymes.
To check the digestion pattern of eDNA and compare
with genomic DNA, eDNA was digested with six diﬀerent
restriction enzymes BamHI, EcoRI, HindIII, PstI, XbaI,
and XhoI( S i g m aA l d r i c h ) .B r i e ﬂ y ,5 μg of eDNA were
mixed with ﬁve units of each restriction enzymes along
with respective enzyme reaction buﬀers and bovine serum
albumin (100mg/mL) and incubated at 37◦C for two hours.
eDNA was also treated with DNase I (10mg/mL, SigmaThe Scientiﬁc World Journal 3
Aldrich), RNase A (10mg/mL, Sigma Aldrich, USA), and
Proteinase K (10mg/mL, Sigma Aldrich, USA). The digested
DNAfragmentswereseparatedbyagarosegelelectrophoresis
and documented in a Gel Documentation system (Alpha
Innotech, USA). Results were compared with those of
genomic DNA.
2.6. Ampliﬁcation of 16SrRNA, 5 coding Region of bap and
blaPER-1.I n v i t r o ampliﬁcation was performed for detection
of 16SrRNA and blaPER-1 (encoding PER-1 type extended
spectrum β-lactamases) in eDNA using PCR primers 16S-
F/R and bla-F/R [9], and a 5 coding region of bioﬁlm-
associated protein (1019bp, position: 152-1171-c) using
primers 1124/1125 [33]. Annealing temperatures were used
forPCRaccordingtoeachprimerset,thatis,16SrRNA:63 ◦C,
bap: 60.5◦C, and blaPER-1: 36.5◦C. The ﬁnal PCR program
used was 94◦C for 5min, 40 cycles at 94◦Cf o r4 5 s e c ,
63◦C/60.5◦C/36.5◦C for 45sec, 72◦C for 60sec/60sec/90sec,
and ﬁnal extension at 72◦C for 5min, respectively, for
16SrRNA, bap, and blaPER-1. PCR reagents and primers
were sourced from Sigma Aldrich, USA, and assayed in
a gradient PCR (Eppendorf, Germany). All PCR assays
were repeated at least thrice, using DNase, RNase, and
protease free water (Bangalore GeNei, India) as a negative
control and genomic DNA as a positive PCR control. PCR
fragments were electrophoresed in 1.5% agarose gels stained
with 0.5μg/mL ethidium bromide and photographed in Gel
Documentation system (Alpha Innotech, USA). Amplicons
were puriﬁed using a gel extraction kit (Sigma Aldrich, USA)
according to manufacturer’s instructions.
2.7. DNA Sequencing. Puriﬁed PCR products were se-
quenced in a DNA Analyzer using Big Dye Terminator
cycle sequencing reaction kit (Applied Biosystems, USA).
Sequencing products were puriﬁed using a commercial kit
(Applied Biosystems, USA) as per manufacturer’s instruc-
tions. Sequences were analyzed using Sequencing Analysis
Software (Applied Biosystems, USA). All Sequencing reac-
tions were performed in triplicates. 16SrRNA and 5 coding
region of bap sequences were submitted to GenBank, NCBI
(National Centre for Biotechnology Information, USA).
2.8. Screening for Presence of Integrative Phages. To check for
the presence of integrative phages which may contribute to
the total available eDNA in the cell-free supernatant, pro-
phage induction in A. baumannii AIIMS 7 was investigated
by UV irradiation and Mitomycin C, according to methods
described [34] with required modiﬁcations. Brieﬂy, an
overnight grown culture of A. baumannii AIIMS 7 was
diluted 1:100 in Luria broth and absorbance was taken at
600nm, followed by incubation in a water bath for 30min
at 37◦C. Mitomycin C was added to a ﬁnal concentration
of 0.5μg/mL and incubated for six hours monitoring the
absorbance at each hour. The suspension was centrifuged
at 3000g for 12min and the supernatant was collected. To
investigate UV irradiation-induced prophages, an overnight
grown culture of A. baumannii AIIMS 7 was diluted 1:50
in Luria broth and incubated at 37◦C for three hours,
followed by centrifugation at 6000g for 10min. The pellet
was resuspended in 100mM MgSO4 and transferred to a
sterile glass Petri plate followed by irradiation for 30 seconds
by keeping at 16cm from the germicidal short wave lamp.
The supernatants from both experiments were tested for
prophage presence by spot test and double-layered plaque
assay.
2.9. Test for Natural Transformation. It was necessary to
evaluate whether A. baumannii AIIMS 7 undergoes natural
transformation, since eDNA could be associated with the
process. To rule out the probability, natural transformation
was tested in A. baumannii AIIMS 7 according to methods
described earlier [35].
2.10. Bioﬁlm Augmentation Assay. To demonstrate the role
of eDNA in bioﬁlm development, overall increase in bioﬁlm
matrix was taken as a measure for calculating bioﬁlm
augmentation. Five diﬀerent preparations containing eDNA
were chosen on the basis that they contain eDNA in one or
more forms. The preparations were, namely, puriﬁed eDNA,
cell-free supernatant (CFS), concentrated CFS (15× CFS),
whole cell lysate, and membrane vesicle suspension. Puriﬁed
eDNA and membrane vesicle suspension were prepared
according to methods described earlier and were used for
the assays. Cell-free supernatant (CFS) was directly used
in bioﬁlm augmentation. It was further concentrated to 15
times (15×), by freeze drying for 14 hours in a lyophilizer
(Thermo, USA). Whole cell lysate was prepared taking
the cell pellet (10mg dry weight) from overnight grown
suspension culture. The pellet was resuspended with 200μL
molecular grade water and heated for 20min at 100◦C. The
lysate was then sonicated and vortexed rigorously for 10min.
Presence of eDNA was checked in all the preparations, by
agarose gel electrophoresis, and results were documented
in Gel Documentation system (Alpha Innotech, USA).
Membrane vesicles were lysed by heat treatment and treating
with 1% sodium dodecyl sulphate (SDS) prior to loading on
the agarose gel. Luria broth was loaded as negative control.
Bioﬁlm quantiﬁcation was done according to methods
described elsewhere [9]. Overnight grown culture of A.
baumannii AIIMS 7 (106CFU/mL) was inoculated onto
single microtitre wells with ﬁnal dilution of 1:40 with sterile
Luria broth and incubated at 37◦C for bioﬁlm development
as control sample. Cell-free supernatant was replaced with
Luria broth for the ﬁrst variation, whereas 20μLe a c ho f
whole cell lysate, 15× CFS, membrane vesicle suspension
and puriﬁed eDNA were individually supplemented to
Luria broth and inoculated with 106CFU/mL cells. Negative
controls(nocells)wereincludedforeachoftheexperimental
preparations. The microtitre plates were then incubated
overnight at 37◦C under static conditions and processed
thereafter. Nonadherent cells were removed from microtitre
wells by sonication followed by aspiration. The wells con-
taining bioﬁlm matrices were washed thrice with sterile PBS
and stained with 0.1% gentian violet (HiMedia, India) for
10min at room temperature. Excess stain was removed by
immersing in a water trough and dried in laminar air ﬂow.4 The Scientiﬁc World Journal
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Figure 1: (a) Growth curve of Acinetobacter baumannii AIIMS 7.
(b) Pattern of eDNA release in temporal scale of A. baumannii
AIIMS 7 growth. Graph representing concentrations of eDNA
puriﬁed from cell-free supernatant of A. baumannii AIIMS 7 at
respective time points. The pattern shows a depression at 48 hour,
otherwise showing almost steady presence of eDNA in extracellular
medium. (Concentrations of eDNA: 490 ± 54.74, 515 ± 40, 505 ±
39.05, 350 ± 17.55, 475 ± 20.56, 440 ± 20.61, 455 ± 27.83, 525 ±
44.43μg/mL,respectively,at12,24,36,48,60,72,84,and96hours).
Finally, 200μL of absolute ethanol was added to each well
shaken at 1020rpm for 10 seconds. Absorbance at 570nm
was recorded in a Multi-Plate Reader (Molecular Devices,
USA). Bioﬁlm indices were calculated after normalizing with
appropriate controls. All bioﬁlm assays were repeated thrice
(in replicates of twelve for each variation).
2.11. Treatment of Preformed Bioﬁlms with DNase I. To
investigate the role of eDNA during bioﬁlm development,
preformed bioﬁlms of A. baumannii AIIMS 7 on polystyrene
m i c r o t i t r ew e l l sw e r et r e a t e dw i t h2m g / m LD N a s eI( S i g m a
Aldrich, USA). Bioﬁlm formation was quantiﬁed according
to methods described previously [9].
2.12. Statistical Analysis. Results obtained (in replicates)
from nucleic acid quantiﬁcation and bioﬁlm assays were
entered in to excelspreadsheets (Microsoft, USA). Frequency
distributions, namely, mean with standard deviations were
determined. Statistical analysis was performed by Student’s
two tailed t-test, and P value < 0.05 was considered to be
statistically signiﬁcant.
2.13. Nucleotide Sequence Accession Numbers. The accession
numbers of 16SrRNA and 5 coding region of bap sequences
(ampliﬁed from eDNA) was HM992508 and HM765514,
respectively.
3. Results
3.1. Presence of eDNA in Extracellular Growth Medium. To
check the presence of DNA in the extracellular growth
medium of A. baumannii AIIMS 7, eDNA was puriﬁed by
isopropanol precipitation at ice-cold temperature. eDNA
was found to be present along the temporal scale of A.
baumannii AIIMS 7 growth up to 96 hours and showed
a pattern as shown in graph (Figure 1(b)). The pattern of
eDNA (Figure 1(b)) showed almost similar concentrations
of eDNA in the early growth phase (up to 36 hours), a fall
in the mid-stationary phase (48 hour), followed by steady
concentrations in the late growth phases (60 to 96 hours).
Correlation of growth curve (Figure 1(a)) and concentration
of puriﬁed eDNA showed that the prevalence of eDNA was
almostconsistent.ConcentrationsofeDNAwerecomparable
to earlier ﬁndings in Pseudomonas aeruginosa [15].
3.2. Membrane Vesicles Present in Extracellular Growth Me-
dium Contained DNA. Membrane vesicles were puriﬁed
from cell-free supernatant (early growth phase) and char-
acterized using electron microscopy to determine their size
and morphology. Electron microscopy revealed presence of
membrane vesicles of varying diameter from 20 to 200nm
(Figures 2(a)–2(c)) and atomic force microscopy conﬁrmed
the dimensions as seen in the two-dimensional picture
(Figure 2(d)).
They were seen as round, regular structures, with bi-
layered membrane encapsulating electron-dense material
(Figure 2(c)).Uranylacetatewasusedfornegativestainingof
membrane vesicles, which preferentially stains nucleic acids.
The dark stained portion in the core could be indicative of
membrane vesicles containing nucleic acids, which could be
DNA, RNA, and even plasmids. In the literature, membrane
vesicles are reported to contain nucleic acid and even
functional enzymes. It was further conﬁrmed when DNA
was visualized in an agarose gel when lysed membrane
vesicle suspension was loaded (Figure 5,L a n e3 ) .T h es i z eo f
DNA found inside membrane vesicles was similar to that of
eDNA (Figure 5, Lane 2) and, therefore, could be a result of
encapsulation during the process of vesiculation.
3.3. Absence of Integrative Phages Indicated eDNA to Be Ex-
clusively of Bacterial Origin. Both spot test and double-
layeredplaqueassayshowednegativeresults:noplaqueswere
observed even 96 hours after incubation at 37◦C conﬁrming
absence of integrative phages in A. baumannii AIIMS 7. This
indicatesthateDNAcharacterizedfromcell-freesupernatant
was exclusively from this organism. The exclusivity of theThe Scientiﬁc World Journal 5
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Figure 2: Visualization of membrane vesicles released from A. baumannii AIIMS 7 by Transmission Electron and Atomic Force Microscopy.
(a-b):TransmissionElectronMicrographsofmembranevesiclespuriﬁedfrom AcinetobacterbaumanniiAIIMS7,afternegativestainingwith
Uranyl acetate. (Bar, 100nm). (c): Single membrane vesicle showing clear outer vesicular membrane with electron-dense core, indicating
presence of nucleic acid. (Bar, 20nm). (d): Atomic Force Micrograph of membrane vesicle suspension (X, Y range: 200nm, Z range:
7.146nm). Arrows indicate individual membrane vesicles.
origin of eDNA in the medium was further conﬁrmed by
amplifying the A. baumannii 16SrRNA gene by PCR.
3.4. A. baumannii AIIMS 7 Did Not Exhibit Natural Trans-
formation. A. baumannii AIIMS 7 did not show ability
to undergo natural transformation unlike several members
of the genus Acinetobacter capable of uptake and release
of DNA [22]. In naturally competent strains, extracellular
DNA could be found in the extracellular environment,
for the accomplishment of natural transformation events,
for example, induction of competence, translocation of
DNA with the competence protein machinery, and ﬁnally
transport across the membrane for both uptake as well as
release. But A. baumannii strains have rarely been seen to
undergo natural transformation and similar results were
obtained with A. baumannii AIIMS 7. This suggested that
the eDNA was released via processes other than natural
transformation.
3.5. Characteristics of eDNA Were Similar to Genomic DNA.
The digestion pattern of eDNA with DNase I and restric-
tion enzymes (BamHI, EcoRI, HindIII, PstI, XbaI, XhoI)
was similar to genomic DNA. Agarose gel electrophoresis
indicated that the size of eDNA is comparable to that of
genomic DNA (>21.2 kb). eDNA was completely digested
with DNaseI (Figure 3), but remained unaﬀected under
RNase and Proteinase K. PCR ampliﬁcation of 16SrRNA,
blaPER-1,a n dbap from eDNA showed bands and sizes (1.56 The Scientiﬁc World Journal
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Figure 3: Comparison of digestion pattern of eDNA and genomic
DNA (by DNase I and restriction enzymes). Agarose gel (0.8%)
showingLane1:GenomicDNA,Lane2:DigestionofgenomicDNA
with DNase I, Lane 3: Digestion of genomic DNA with restriction
enzymes (BamHI, EcoRI, HindIII, PstI, XbaI, XhoI), Lane M:
Molecular weight marker (λ phage genome EcoRI/HindIII digest),
Lane 4: Digestion of eDNA with restriction enzymes (BamHI,
EcoRI, HindIII, PstI, XbaI, XhoI), Lane 5: Digestion of eDNA with
D N a s eI ,L a n e6 :P u r i ﬁ e de D N A .
kb, 837bp, and 1025bp, resp.) on agarose gel similar to those
from the genomic DNA of A. baumannii AIIMS 7 (Figures
4(a)–4(c)).
3.6. A. baumannii Bioﬁlms Were Signiﬁcantly Augmented
by eDNA. We were interested in studying the eﬀect on
bioﬁlm development when DNA was made available exter-
nally. We supplemented bioﬁlms with eDNA in various
preparations to mimic its natural availability during growth.
Figures 6(a)–6(e) shows that eDNA supplemented in any
of the given forms was able to augment the bioﬁlms on
polystyrene microtitre surface signiﬁcantly. However, there
was a mild variation in bioﬁlm augmentation capabilities
of the supplements which contained eDNA. Similar levels
of augmentation were observed with membrane vesicles
containing DNA, whole cell lysate, and puriﬁed eDNA and
genomic DNA (Figures 6(a), 6(b), 6(c),a n d6(e)). Cell-free
supernatant (CFS) and its concentrated form (15× CFS)
conferred maximum bioﬁlm augmentation (211.19% and
224.64%, resp., Figure 6(d)). Overall, based on the results of
bioﬁlm augmentation, it was inferred that presence of eDNA
in the vicinity of cells attached to surface can favorably lead
to a more abundant development of bioﬁlm, which may vary
upon the environment and conditions in which eDNA is
present.
3.7. Preformed Bioﬁlm of A. baumannii Was Inhibited by
DNase I. Treatment of preformed A. baumannii bioﬁlms
with DNase I showed reduction in bioﬁlm biomass up to
59.41% (Figure 6(f)). In several bacterial bioﬁlms, presence
of DNA in the bioﬁlm matrix makes the bioﬁlm stable
due to its polymeric and polyionic nature. This experiment
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Figure 4: PCR ampliﬁcation of 16SrRNA, 5 coding region of bap
and blaPER-1 from genomic DNA and eDNA. Agarose gel (1.5%)
showing (a): Lane M: Molecular weight marker (values in kb), Lane
1: 16SrRNA (1.5kb) ampliﬁed from genomic DNA, and Lane 2:
16SrRNA (1.5kb) ampliﬁed from eDNA. Lane 3: DNase, RNase,
Protease-freewaterasnegativePCRcontrol.(b):LaneM:Molecular
weight marker (values in kb), Lane 1: 1019bp sized 5 coding region
of bap gene ampliﬁed from genomic DNA, and Lane 2: 1019bp
sized 5 coding region of bap gene ampliﬁed from eDNA, Lane 3:
DNase, RNase, Protease-free water as negative PCR control. (c):
Lane M: Molecular weight marker (values in kb), Lane 1: 875bp
blaPER-1 gene ampliﬁed from genomic DNA, Lane 2: 875bp blaPER-1
gene ampliﬁed from eDNA, and Lane 3: DNase, RNase, Protease-
f r e ew a t e ra sn e g a t i v eP C Rc o n t r o l .
explained that deﬁciency of DNA in the bioﬁlm matrix can
lead to severe reduction of bioﬁlm biomass. It is also direct
evidence that abiotic (polystyrene) surface bioﬁlms of A.
baumannii AIIMS 7 were signiﬁcantly dependent upon the
presence of eDNA.
4. Discussion
Extracellular DNA can be of genomic origin [35],and its role
has been reported earlier in several other bacteria, but there
are no reports as yet in A. baumannii. In our study, eDNA
has been characterized from a clinical strain of A. baumannii
and its role in bioﬁlm development is demonstrated for the
ﬁrst time. The characteristics of eDNA were very similar to
those of genomic DNA, as seen in agarose gels, and further
conﬁrmed by in vitro ampliﬁcation of 16SrRNA, blaPER-1
,a n d5  coding region of bap.T h i si si na g r e e m e n tw i t h
studies [16] which showed ampliﬁcation of several Staphylo-
coccus epidermidis genes from its eDNA and compared with
genomic DNA. Similarly, in Pseudomonas aeruginosa and
Pseudomonas putida bioﬁlms, eDNA is similar to genomic
DNA [13]. eDNA can serve as raw material for gene transferThe Scientiﬁc World Journal 7
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Figure5:AnalysisofeDNApresentinvariouspreparationsusedfor
bioﬁlm augmentation. Agarose gel (0.8%) showing Lane 1: Luria
broth control, Lane 2: puriﬁed eDNA, Lane 3: lysed membrane
vesicle suspension, Lane 4: cell-free supernatant (CFS), Lane 5:
concentrated cell-free supernatant (15× CFS), and Lane 6: whole
cell lysate. DNA can be seen well separated on agarose gel (Lanes
2,3: puriﬁed eDNA and DNA from membrane vesicles); however,
in case of CFS, 15× C F S ,a n dw h o l ec e l ll y s a t e( l a n e4 ,5 ,6 . ) ,i tc a n
be seen in the wells.
[23], as in the case of naturally transformable bacteria like
Acinetobacter sp.BD413. However, this was not the case of A.
baumannii AIIMS 7 since the strain did not exhibit natural
transformation.
During in vitro growth of A. baumannii,w ea n a l y z e d
the concentrations of eDNA available in the extracellular
medium (cell-free supernatant) up to 96 hours, which
described a novel pattern of prevalence. Based on eDNA
release pattern and growth curve in the temporal scale
(Figures 1(a) and 1(b), the origin of eDNA in A. baumannii
AIIMS 7 was attributed to three major processes: (i) active
release of eDNA in free form, (ii) encapsulation of eDNA
by membrane vesicles released (early growth stages), and
(iii) passive release of eDNA during cell lysis (later stages of
growth).
(i) A. baumannii eDNA at early stages indicates active
release of DNA which is independent of lysis. Com-
parable ﬁndings are described in earlier studies in
P. aeruginosa [15]. Autolysin-mediated eDNA release
and bioﬁlm formation is shown in Enterococcus
faecalisand Staphylococcus epidermidis [16, 17]. It is
interesting to speculate whether or not A. baumannii
harbors a mechanism for eDNA release by regu-
lated lysis of a subpopulation to promote bioﬁlm
formation. No experimental data records exist to our
knowledge, except presence of an autolysin-like ORF
i nw h o l eg e n o m em a po fA. baumannii AB0057 [36].
A fall in eDNA concentration seen at mid-stationary
phase (48 hours), however, remained unclear. Nutri-
ent limitation, growth inhibition, accumulation of
secondarymetabolites, andprobabledownregulation
ofputativeautolysingenescouldbeprobablereasons.
(ii) Membrane vesicles are released during in vitro
growth of A. baumannii, according to recent studies
[37, 38]. Here, we report release of membrane
vesicles for the ﬁrst time, seen in an Indian clinical
isolate A. baumannii AIIMS 7. These MVs contained
DNA, which was conﬁrmed by localization by elec-
tron microscopy after uranyl acetate staining, and
subsequently by electrophoresis of vesicular DNA.
Vesicular DNA has been reported to be ampliﬁable
in case of other Gram-negative bacteria [39]s u c h
as Escherichia coli O157:H7 [31]a n dPseudomonas
aeruginosa PA01 [40] and was seen in this study
as well (16SrRNA, blaPER-1 genes; data not shown).
Theelectrondensematerialpresentinsidemembrane
vesicles explains that DNA could be encapsulated
during active growth; therefore, release of membrane
vesicles into the extracellular growth medium can
contribute signiﬁcantly to the total availability of
eDNA.
(iii) Any eDNA seen during the log phase of growth
should mostly be due to active secretion mechanisms
and not due to cell death. High concentration of
eDNA at later stages of growth (post-48 hours) can
be attributed to cell lysis leading to passive release
of DNA into the extracellular medium. 16SrRNA
ampliﬁcation from eDNA conﬁrmed that the DNA
available in the medium may comprise fractions of
genomic DNA. Nevertheless, the actively released
eDNA, membrane vesicles (containing DNA), and
putative autolysin-mediated eDNA release would
account for the major fraction of total eDNA at the
earlier stages of growth (up to 36 hours).
eDNA is a matrix component of microbial bioﬁlms [41]
and is involved in the process of bioﬁlm formation, as
earlierdemonstratedinseveralbacteria,forexample,Bacillus
cereus, Staphylococcus epidermidis, and Enterococcus faecalis
[16, 17, 42]. eDNA is essential for initiation and stabilization
ofbioﬁlms.Asreviewedearlier[43],bacterialeDNA(present
as a component of the bioﬁlm EPS) is involved in essential
functions such as initial adhesion, aggregation of cells, and
cohesion of bioﬁlms to provide mechanical stability. The role
of eDNA in these developmental processes can be largely in
combination with other components present in EPS such
as polysaccharides, proteins, and amphiphilic molecules. In
Pseudomonas aeruginosa, a similar phenomenon is observed
w h e r ee D N Aa c t sa sas c a ﬀolding agent [14]a n da n
intracellular connector [44]. Being polyionic, eDNA can
link other molecules together on the bioﬁlm matrix as like
teichoic acid. Similar observations have been reported in
Staphylococcus aureus bioﬁlms, which suggest that eﬀect of
DNase was observed due to the direct action of DNase
on the bioﬁlm matrix which contained DNA, independent
of growth pattern or cell number [45]. Augmentation of
bioﬁlms by external supplementation of eDNA, and the
inhibitory eﬀect of DNase I on A. baumannii bioﬁlms as
shown here, proves that progressive bioﬁlm development in
A. baumannii is dependent on availability of eDNA.
Our study highlights the importance of eDNA demon-
strated through bioﬁlm augmentation assays. It demon-
strates that irrespective of its origin whether from active
eDNA release, contained inside membrane vesicles, or from
natural cell lysis, eDNA is crucial for bacterial bioﬁlms.
eDNA can be eﬃciently taken up for building of bioﬁlm
matrix and can well serve as scaﬀolding agent during
bacterial aggregation and stabilization of bioﬁlms [14, 44].8 The Scientiﬁc World Journal
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Figure 6: Quantitative bioﬁlm assays for A. baumannii AIIMS 7. Representative graphs showing bioﬁlm augmentation after external
supplementation with (a): puriﬁed eDNA (178.83% augmentation); (b): puriﬁed genomic DNA (170.79% augmentation); (c): puriﬁed
membrane vesicle suspension (170.11% augmentation); (e): whole cell lysate (167.89% augmentation); (d): bioﬁlm augmentation seen after
replacingLuriabrothwithcell-freesupernatant(CFS;211.19%augmentation)andsupplementationwith15×CFS(224.64%augmentation)
(f): Eﬀect of DNase I treatment on preformed bioﬁlms. (59.41% reduction).
eDNA also forms deﬁned network-like structure during
bioﬁlm development, and, therefore, imparts stability [46].
We observed that the cell-free supernatant (in concentrated
form, 15× CFS) shows maximum augmentation of bioﬁlm,
since eDNA present in free form can be easily made available
across the surface of bioﬁlm and has more chance of making
scaﬀolds and thereby increasing the biomass by adhering to
other matrix components by ionic interactions. The whole
cell lysate supplementation mimicked the availability of
eDNA at later stage, that is, passive release of DNA from
lysed cells. It was seen to augment the bioﬁlm (167.89%;
Figure 6(e)) suggesting that DNA from culture in late
growth phase may also contribute to growing or freshly
dispersed bioﬁlms. Membrane vesicles are known to help
in bioﬁlm enrichment, as shown in earlier studies in P.
aeruginosa [40]. Similar results were seen with A. baumannii
membrane vesicles (present study), which exhibited bioﬁlm
augmentation equivalent to that by puriﬁed genomic DNA,
eDNA, or whole cell lysate.
Collectively,thisworkdemonstratesthateDNAispresent
in the extracellular milieu, during in vitro growth of A.
baumannii AIIMS 7. Besides originating from cell lysis at
later stages, eDNA results from active release at early growth
phases either in free form or contained in membrane vesiclesThe Scientiﬁc World Journal 9
of diameter 20–200nm. eDNA in any of its natural forms is
able to augment A. baumannii bioﬁlms on an abiotic surface
to signiﬁcant levels, evident of having a role in progressive
bioﬁlm formation. Furthermore, preformed bioﬁlms were
inhibited by DNase I, supporting the role of eDNA in
bioﬁlms. DNA has been a target for inhibiting bioﬁlms of
P. aeruginosa [47] and, therefore, can have potential for
combination therapy (with antibiotics) in the treatment of
bioﬁlm-associated infections caused by multidrug-resistant
A. baumannii, which, however, warrants further experimen-
tal validation.
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